• Something wrong with this record ?

Novel neuroprotective 5,6-dihydropyrido[2',1':2,3]imidazo[4,5-c]quinoline derivatives acting through cholinesterase inhibition and CB2 signaling modulation

S. Jena, G. Gonzalez, D. Vítek, M. Kvasnicová, Š. Štěpánková, M. Strnad, J. Voller, K. Chanda

. 2024 ; 276 (-) : 116592. [pub] 20240617

Language English Country France

Document type Journal Article

A novel group of 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinolines was prepared via a microwave assisted one-pot telescopic approach. The synthetic sequence involves the formation of an amine precursor of imidazo [1,2-a]pyridine via condensation and reduction under microwave irradiation. Subsequently, the Pictet-Spengler cyclisation reaction occurs with ketones (cyclic or acyclic) to obtain substituted 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinolines in excellent yields. The compounds were tested as neuroprotective agents. Observed protection of neuron-like cells, SH-SY5Y differentiated with ATRA, in Parkinson's and Huntington's disease models inspired further mechanistic studies of protective activity against damage induced by 1-methyl-4-phenylpyridinium (MPP+), a compound causing Parkinson's disease. The novel compounds exhibit similar or higher potency than ebselen, an established drug with antioxidant activity, in the cells against MPP + -induced total cellular superoxide production and cell death. However, they exhibit a significantly higher capacity to reduce mitochondrial superoxide and preserve mitochondrial membrane potential. We also observed marked differences between a selected derivative and ebselen in terms of normalizing MPP + -induced phosphorylation of Akt and ERK1/2. The cytoprotective activity was abrogated when signaling through cannabinoid receptor CB2 was blocked. The compounds also inhibit both acetylcholine and butyrylcholine esterases. Overall the data show that novel 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinoline have a broad cytoprotective activity which is mediated by several mechanisms including mitoprotection.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018724
003      
CZ-PrNML
005      
20241024111232.0
007      
ta
008      
241015e20240617fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejmech.2024.116592 $2 doi
035    __
$a (PubMed)39013357
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Jena, Sushovan $u Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India
245    10
$a Novel neuroprotective 5,6-dihydropyrido[2',1':2,3]imidazo[4,5-c]quinoline derivatives acting through cholinesterase inhibition and CB2 signaling modulation / $c S. Jena, G. Gonzalez, D. Vítek, M. Kvasnicová, Š. Štěpánková, M. Strnad, J. Voller, K. Chanda
520    9_
$a A novel group of 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinolines was prepared via a microwave assisted one-pot telescopic approach. The synthetic sequence involves the formation of an amine precursor of imidazo [1,2-a]pyridine via condensation and reduction under microwave irradiation. Subsequently, the Pictet-Spengler cyclisation reaction occurs with ketones (cyclic or acyclic) to obtain substituted 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinolines in excellent yields. The compounds were tested as neuroprotective agents. Observed protection of neuron-like cells, SH-SY5Y differentiated with ATRA, in Parkinson's and Huntington's disease models inspired further mechanistic studies of protective activity against damage induced by 1-methyl-4-phenylpyridinium (MPP+), a compound causing Parkinson's disease. The novel compounds exhibit similar or higher potency than ebselen, an established drug with antioxidant activity, in the cells against MPP + -induced total cellular superoxide production and cell death. However, they exhibit a significantly higher capacity to reduce mitochondrial superoxide and preserve mitochondrial membrane potential. We also observed marked differences between a selected derivative and ebselen in terms of normalizing MPP + -induced phosphorylation of Akt and ERK1/2. The cytoprotective activity was abrogated when signaling through cannabinoid receptor CB2 was blocked. The compounds also inhibit both acetylcholine and butyrylcholine esterases. Overall the data show that novel 5,6-dihydropyrido [2',1':2,3]imidazo [4,5-c]quinoline have a broad cytoprotective activity which is mediated by several mechanisms including mitoprotection.
650    _2
$a lidé $7 D006801
650    12
$a neuroprotektivní látky $x farmakologie $x chemie $x chemická syntéza $7 D018696
650    12
$a cholinesterasové inhibitory $x farmakologie $x chemie $x chemická syntéza $7 D002800
650    12
$a chinoliny $x farmakologie $x chemie $x chemická syntéza $7 D011804
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    12
$a signální transdukce $x účinky léků $7 D015398
650    12
$a receptor kanabinoidní CB2 $x metabolismus $x antagonisté a inhibitory $7 D043885
650    _2
$a molekulární struktura $7 D015394
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a zvířata $7 D000818
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gonzalez, Gabriel $u Department of Experimental Biology, Palacky University Olomouc, Faculty of Science, Šlechtitelů 27, 78371, Olomouc, Czech Republic; Department of Neurology, University Hospital in Olomouc, I. P. Pavlova 6, 77520, Olomouc, Czech Republic
700    1_
$a Vítek, Dominik $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 5, 77515, Olomouc, Czech Republic
700    1_
$a Kvasnicová, Marie $u Department of Experimental Biology, Palacky University Olomouc, Faculty of Science, Šlechtitelů 27, 78371, Olomouc, Czech Republic; Laboratory of Growth Regulators, Faculty of Science, Palacký University Olomouc, and Institute of Experimental Botany of the Czech Academy of Sciences, Šlechtitelů 27, CZ-78371, Olomouc, Czech Republic
700    1_
$a Štěpánková, Šárka $u Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 53210, Pardubice, Czech Republic
700    1_
$a Strnad, Miroslav $u Laboratory of Growth Regulators, Faculty of Science, Palacký University Olomouc, and Institute of Experimental Botany of the Czech Academy of Sciences, Šlechtitelů 27, CZ-78371, Olomouc, Czech Republic
700    1_
$a Voller, Jiří $u Department of Experimental Biology, Palacky University Olomouc, Faculty of Science, Šlechtitelů 27, 78371, Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 5, 77515, Olomouc, Czech Republic. Electronic address: jiri.voller@upol.cz
700    1_
$a Chanda, Kaushik $u Department of Chemistry, Rabindranath Tagore University, Hojai, Assam, 782435, India. Electronic address: chandakaushik1@gmail.com
773    0_
$w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 276 (20240617), s. 116592
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39013357 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111226 $b ABA008
999    __
$a ok $b bmc $g 2201535 $s 1230697
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 276 $c - $d 116592 $e 20240617 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
LZP    __
$a Pubmed-20241015

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...